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The ICAM-1/LFA.1 interaction in glomerular leukocytic accumulation
in anti-GBM glomerulonephritis. Recent studies of rat anti-glomerular
basement membrane (anti-GBM) disease have demonstrated a func-
tional role for ICAM-l in the entry of leukocytes into the glomerulus,
both in the early polymorphonuclear (PMNL) influx and the more
delayed monocyte/macrophage infiltration. In the current study we
used immunogold ultrastructural techniques to identify the exact sites
of expression of ICAM-I (CD54) in the glomerulus and the expression
of CDI Ia and CDI8 by infiltrating glomerular leukocytes in the first 24
hours of accelerated anti-GBM disease in rats. In normal rats there was
constitutive ICAM-l expression on the luminal surface of the glomer-
ular endothelium and parietal epithelium of Bowman's capsule, In
disease ICAM-l expression was progressively increased over 24 hours
on a thickened, reactive glomerular endothelium, being most prominent
on endothelium adjacent to the mesangial stalks. Mesangial cells
demonstrated surface ICAM-l expression only in focal areas of super-
ficial mesangiolysis. PMNL, the predominant glomerular inflammatory
cell in the first 12 hours of accelerated anti-GBM ON, expressed
abundant surface CDI8 which was present at the sites of adhesion of the
PMNL to the glomerular endothelium. In contrast PMNL expressed
only very sparse surface CDI Ia, suggesting that another /32 integrin,
Mac-l, which shares a common 13 chain with LFA-l may be the more
important PMNL counter receptor for ICAM-l in the glomerulus.
Glomerular monocyte/macrophage infiltration became evident within
glomerular capillary loops and the mesangium from 6 to 24 hours. These
adherent and migrating leukocytes expressed abundant surface CD! la
and moderate CD18 particularly at their sites of adhesion to glomerular
endothelium. The presence of both CD! la and CD18 suggest that
LFA-l is the important macrophage counter receptor for ICAM-l in
anti-GBM GN. This is the first study to precisely localize the sites of
glomerular ICAM-l in glomerulonephritis. The results suggest that the
up-regulation of glomerular endothelial ICAM- 1 plays a role in the early
adhesion and localization of glomerular PMNL via the Mac-i ligand and
the later adhesion and migration of macrophages via the /32 integrin
LFA-l.
ular damage in experimental anti-GBM GN [2—5]. These studies
have shown that intercellular adhesion molecule-i (ICAM-!,
CD54) appears to be functionally the most important adhesion
molecule in directing glomerular leukocytic infiltration in the
early phase of the disease [3, 5]. ICAM-l, a cell surface
glycoprotein and a member of the immunoglobulin superfamily
is expressed on many cell types including endothelium [6].
ICAM- 1 has as its ligands members of the /32 integrin family:
lymphocyte function-associated antigen (LFA-l, CD11aJ
CD18), expressed on most leukocytes [7, 8]; and macrophage-l
(Mac-i, CD! lb/CD!8) expressed by PMNL and macrophages
[9, 10].
Although a number of light microscopy studies have exam-
ined ICAM-1 expression in human glomerulonephritis [11—14]
and munne autoimmune lupus nephritis [15], the exact local-
ization of ICAM-! in giomeruionephritis remains to be estab-
lished. Therefore the aim of this study was to determine the
precise ultrastructural localization of ICAM-! expression
within the glomerulus, the characterization of CD! la and/or
CD18 expressing glomerular leukocytes and the sites of inter-
action of these leukocytes with ICAM-1 expressing cells in the
early stages of glomerular leukocytic infiltration in an acceler-
ated model of anti-GBM GN in the rat.
Methods
Animals
Inbred male Sprague-Dawley (SD) rats aged three to four
months were obtained from the Monash Medical Centre Animal
House.
Experimental anti-GBM glomerulonephritis
Experimental anti-glomerular basement membrane glomeru-
lonephritis (anti-GBM GN) is characterized by a glomerular
lesion with an early polymorphonuclear leukocyte (PMNL)
influx and endothelial damage, and a more delayed monocyte/
macrophage infiltration with fibrin accumulation [1].
Recent studies have demonstrated the importance of various
adhesion molecules in the leukocytic accumulation and glomer-
Rabbit nephrotoxic serum (NTS) was raised as previously
described [16]. Passive accelerated anti-GBM GN was induced
in SD rats by subcutaneous immunization with 5 mg of normal
rabbit IgG (Silenus, Australia) in Freund's adjuvant followed
five days later by intravenous injection of NTS (10 mllkg body
wt). Groups of two animals were sacrificed at 1.5, 6, 12 and 24
hours. A group of normal animals was used as controls.
Monoclonal antibodies
Received for publication August 26, 1993
and in revised form October 25, 1993
Accepted for publication October 25, 1993
© 1994 by the International Society of Nephrology
Mouse monoclonal antibodies (mAbs) used in this study were
as follows: OX-I [16], rat leukocyte common antigen; ED-!
[161, most macrophages and some dendritic cells; R-73 [16], T
cell receptor; 1A29 [17], rat ICAM-1 (CD54); WT! [18], rat
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LFA-la chain (CDL La); WT3 [181, rat LFA-1f3 chain (CD18).
1A29, WT1 and WT3 mAbs were supplied by Serotec (Austra-
han Laboratory Services, Melbourne, Australia).
Immunohistochemistry
Kidney for immunoperoxidase staining was immersion fixed
in periodate-lysine-paraformaldehyde (PLP) for two hours and
serial 6 cryostat sections were cut and stained as previously
described [161. The mAbs were visualized with a three-layer
immunoperoxidase technique using peroxidase conjugated goat
anti-mouse IgG and mouse peroxidase anti-peroxidase com-
plexes followed by development with 3'3'-diaminobenzidine
(DAB, Sigma) and counterstaining with Harris' hemotoxylin.
For each animal monoclonal mouse anti-human CD45R acted as
a negative control.
ICAM-1 (CD54) mAb labeling of kidney tissue sections was
scored as follows. The number of positive cells per glomerular
cross section (gcs) was semi-quantitatively assessed: <1+,
<25% ofglomerular cells labeled; 1+, 25 to 50% cells labeled;
2+, 50 to 75% cells labeled; and 3+, >75% cells labeled. The
number of cells per gcs labeled by the OX-i, ED-i and RT-3
mAbs was quantitated as previously described [161. All sections
were read in blinded fashion.
Immunoelectron microscopy
The kidneys were perfusion fixed with PLP for five minutes
and then 1 mm thick slices were immersion fixed in PLP for two
hours. The slices were then immersed in increasing concentra-
tions of sucrose (5% up to 20%) in 0.1 M phosphate buffered
saline (PBS) pH 7.4 over 36 hours; then they were placed in
OCT and snap frozen in liquid nitrogen. Subsequently 30
cryostat sections were cut and incubated in 5% normal goat
serum (NGS) in 0.01 M PBS, 0.8% bovine serum albumin (BSA)
and 0.1% lOGS quality gelatin as a blocking step and then in the
primary monoclonal antibodies (1A29, WT1 and WT3) over-
night at 4°C. Monoclonal antibodies were diluted 1 in 75 in 1%
NGS in 0.01 MPBS/0.8% BSA/0. 1% gelatin (dilution buffer) to
a final concentration of 13 jgIml. For each animal control
sections were incubated in dilution buffer only. Sections were
then incubated in goat antimouse IgG labeled with 1 nm gold
particles (Auroprobe One, Amersham) diluted 1 in 25 in dilution
buffer. Following extensive washing, sections were fixed in 2%
glutaraldehyde in PBS for 15 minutes and then silver enhanced
using IntenSE M kit (Amersham). Post-fixation with 1% aque-
ous osmium for 30 minutes was followed by dehydration in
graded acetones and flat embedding of the sections in Epon-
Araldite. Sections 0.08 t thick were cut straight from the
surface of the block, mounted on copper grids, stained with lead
citrate and uranyl acetate and examined in a Philips CM12
electron microscope.
Results
Immunohistochemistry
ICAM-1 was weakly con stitutively expressed (<1+) in nor-
mal glomeruli. There was a progressive up-regulation of gb-
merular ICAM-1 expression in anti-GBM GN with maximal
expression (3+) reached by six hours and maintained through-
out the 24 hours studied. However, the precise localization of
the sites of ICAM-1 within the glomerulus could not be identi-
fied.
An occasional ED1 + macrophage (<1 cell per gcs) was
present in glomeruli in normal animals. In anti-GBM GN the
total number of glomerular leukocytes (OX— 1+) peaked at
three hours with 17 cells per gcs, and then progressively
declined to 10 cells per gcs by 24 hours. The number of ED1 +
glomerular macrophages rose progressively from 1 cell per gcs
at 1.5 hours to 7 cells per gcs at 24 hours. RT3 +T cells were
recorded at <1 cell per gcs at all time points in anti-GBM GN.
Immunoelectron microscopy
Glomerular ICAM-I expression in normal animals. Within
the glomerulus ICAM-l (CD54) was weakly constitutively
expressed on the luminal surface of the fenestrated endothelium
of glomerular capillaries (Fig. 1 a, b). Sparse ICAM-i staining
was also detected on the free surface of the parietal epithelium
lining Bowman's capsule (Fig. lc). The visceral podocytic
epithehium and glomerular mesangium were negative for
ICAM-l. Control sections were negative.
No CDI la or CD18 positive cells were detected in the normal
glomerulus.
Glomerular leukocytic accumulation in disease (anti-GBM
GN). By 1.5 hours and up to 12 hours PMNL were the
predominant glomerular leukocyte and PMNL were present in
most capillary loops. The glomerular accumulation of PMNL
was associated with extensive focal detachment and loss of the
glomerular endothelium. Many PMNL appeared adherent to
bare GBM whereas others showed intimate apposition of their
surface membranes to endothehial membranes, which we have
interpreted as representing adherence of the leukocyte to the
endothehial surface. The rest of the glomerular endothelium
appeared reactive and swollen and these endothehial changes
persisted over the 24 hours studied. Occasional lymphocytes
and platelets, and fibrin were also present in glomerular capil-
lary loops at this early stage. By three to six hours "active
appearing" macrophages began to appear in glomerular capil-
lary loops and by 12 to 24 hours several (3 to 5) macrophages
were identified in most glomeruli examined. These macro-
phages, characterized by abundant cytoplasm containing prom-
inent profiles of granular endoplasmic reticulum, Golgi appara-
tus and numerous cytoplasmic vacuoles were seen adherent to
and migrating beneath gbomerular endothelium and occasionally
within the mesangium. As with PMNL, there were only very
occasional nonadherent macrophages seen in this perfusion
fixed tissue. Small areas of focal superficial mesangiolysis and
early mesangial interposition of gbomerular capillary loops were
present at 6 to 24 hours. By 12 to 24 hours podocytic epithelial
cells demonstrated vacuolation, foot process spreading and
focal detachment and gbomerular fibrin accumulation was prom-
inent.
Glomerular ICAM-1 expression in disease (anti-GBM GN).
ICAM- 1 expression was increased on the luminal surface of the
glomerular endothelium as early as 1.5 hours after induction of
disease and became progressively more pronounced over the 24
hours (Fig. 2a). This up-regulation of ICAM-i expression was
most intense on swollen endothelium adjacent to mesangial
stalks (Fig. 2b). ICAM-l was present on the endothelium at the
sites of PMNL and macrophage adhesion. ICAM-l was also
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Fig. 1. ICAM-1 (CDS4) in normal rat. (a) ICAM-l is weakly constitutively expressed on the luminal surface of the glomerular endothelium
(arrows). Note the absence of ICAM-l staining on mesangial cells (MC) and visceral podocytic epithelium (yE). Abbreviations are: C, glomerular
capillary lumen; E, endothelial cell. x 20,000. (b) At higher magnification ICAM-l expression is seen confined to glomerular endothelial cells
(arrows). x 35.000 (C) ICAM-l is expressed on the free surface of the parietal epithelium (arrows) but not on the lateral or basal surfaces of these
cells. Note also the staining of endothelium of a periglomerular capillary (C). BC, Bowman's capsule X 20,000.
expressed on the surface of macrophages, both adherent and
migrating beneath the glomerular endothelium (Fig. 3 a, b), but
not on the surface of PMNL. ICAM-l was expressed on the
surface of mesangial cells within small focal areas of superficial
mesangiolysis and on those mesangial cells showing early
mesangial interposition of glomerular capillary loops (Figs. 2b
and 3a). In addition ICAM-l was occasionally seen in the
mesangium in the later stages of disease (6 to 24 hr) in
association with migrating mesangial macrophages. ICAM-l
was prominent on the free surface of the parietal epithelium in
disease but was not expressed at any stage on the visceral
podocytic epithelium. Nonspecific gold staining was detected
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Fig. 2. (a) ICAM-1 (CD54) in anti-GBM GN at 12 hours. ICAM-I is strongly expressed on a reactive thickened glomerular endothelium (arrows).
A PMNL (PM) is present within one capillary loop. Note the absence of ICAM-l staining on mesangial cells (MC). C, glomerular capillary loop.
x 10,000. (b) ICAM-1 (CD54) in anti-GBM GN at 24 hours. ICAM-l is very strongly expressed on the swollen glomerular endothelium (E) adjacent
to the mesangial stalk. ICAM-l is also weakly expressed on the surface of mesangial cells (MC) showing early mesangial interposition (arrows).
C, glomerular capillary loop. x 20,000.
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Fig. 3. (a) ICAM-1 in anti-GBM GN at 12
hours. A macrophage (M) is adherent at
several points to the glomerular endothelium
at sites of ICAM-l expression (arrows). In
addition to endothelial expression, ICAM-1 is
also present on the surface of the macrophage
and on the surface of mesangial cells (MC) in
a small area of superficial mesangiolysis
(asterisks). E, glomerular endothelium.
10,000. (b) ICAM-1 in anti-GBM GN at 24
hours. This macrophage (M) which has
migrated beneath the glomerular endotheium
(E) shows sparse surface ICAM-l expression
(arrows) C, glomerular capillary lumen.
x 12,600.
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on bare GBM and in protein reabsorption droplets in damaged
podocytes.
Glomerular CDJJa and CDI8 expression in disease (anti-
GBM GN). CD1 la and CD18 staining was observed solely on
the surface of leukocytes and was present in a fairly even
distribution over the leukocyte membrane. PMNL expressing
strong surface CD18 were seen adherent to and migrating
beneath glomerular endothelium (Fig. 4 a, b). CD1S was present
on the entire PMNL surface, including the sites of adhesion to
the endothelium, but was absent on the PMNL surface adherent
to bare GBM. In contrast CD! la expression was absent or very
weak on the surface of PMNL (Fig. 4c). "Active appearing"
macrophages adherent to and migrating beneath glomerular
endothelium expressed moderate surface CDI8 (Fig. 5a) and
strong surface CD! la (Fig. 5b). Both CD18 and CD! la staining
were present at the sites of macrophage adhesion to the
endothelium which sometimes appeared to be tethered at these
points (Fig. Sc), but was not present on the macrophage surface
adherent to bare GBM (Fig. Sb). In addition CD18 and CDI !a
positivity was seen within macrophage cytoplasmic vacuoles
(Fig. Sb).
Discussion
This is the first study to identify the ultrastructural glomerular
localization of ICAM-1 expression in glomerulonephritis and is
complementary to an earlier ultrastructural study of ICAM-!
and LFA-! expression in the renal interstitium in anti-GBM GN
[19]. The marked up-regulation of ICAM-l expression on gb-
merular endothelium throughout the first 24 hours of anti-GBM
GN in association with the glomerular accumulation of PMNL
(1.5 to 6 hr) and macrophages (6 to 24 hr) lends support to the
proposal that ICAM-! plays a critical role in the glomerular
leukocytic infiltration in this disease [3, 5].
The technique we have chosen to localize ICAM-l and its /32
integrin ligands on the surface of leukocytes is a pre-embedding
method of immunoelectron microscopy using 30 tissue sec-
tions and 1 nm gold with silver enhancement. This technique is
well suited to the localization of molecules expressed on the cell
surface and combines excellent morphologic preservation with
an easily detectable electron-dense label. However, the method
has certain limitations including variable penetration into the
tissue sections and precise control of the final size of the silver
enhanced gold particles. These problems would make quantita-
tion of the staining unlikely to be accurate, and hence this study
focused on the precise localization of glomerular adhesion
molecule expression rather than on its quantitation.
ICAM-1 expression is known to be up-regulated in endothe-
hal cells by the proinflammatory cytokines IL-I, TNF and IFN7
[20, 21] and recent studies in anti-GBM GN have demonstrated
that anti-TNFa abrogates the up-regulation of glomerular
ICAM-l expression in this disease [5]. In addition we have
shown that administration of the IL-i receptor antagonist in
anti-GBM GN in the rat reduces proteinuna, glomerular leuko-
cytic infiltration and crescent formation [22], and glomerular
ICAM-! expression (Nikolic-Paterson, manuscript submitted
for publication). There are several potential sources of these
stimulatory cytokines in glomeruli in anti-GBM GN including
activated endothelial cells, mesangial cells and infiltrating leu-
kocytes [21, 23].
Focal mesangial ICAM-l expression was present in areas of
superficial mesangiolysis and around migrating macrophages
within the mesangium, but this was a relatively minor pattern of
ICAM-1 staining compared to the marked up-regulation of
glomerular endothelial ICAM-! expression in anti-GBM GN.
Mesangial cells in vitro are capable of rapid up-regulation of
ICAM-! expression in response to cytokine stimulation [24].
The lack of significant mesangial staining in this study could be
due to poor penetration of antibodies into the tissue. The
likelihood that there is more fluid flow in locations such as
vessels as compared to the mesangium (unless there is mesan-
giolysis) would result in better antibody access and staining in
these structures.
Adherence/adhesion is difficult to measure on purely morpho-
logic criteria but in this study using tissue processed by perfu-
sion fixation, circulating nonadherent leukocytes are largely
flushed out from blood vessels whereas those cells adherent to
the endothelium remain in situ. We interpreted close apposition
of leukocyte membranes to endothelial membranes as repre-
senting adherence and the presence of immunogold particles at
these sites as representing molecules mediating adherence.
ICAM-i binds to ligands of the /32 integrin family, including
LFA-1 which is expressed on all leukocytes and Mac-i which is
expressed on PMNL and macrophages [7—10]. /32 integnns are
constitutively expressed in the PMNL membrane but require
activation or functional up-regulation by cross linking of PAF or
IL-8 receptors on the PMNL surface [9, 10]. PAF and IL-8 are
both synthesized by endothelium activated by proinflammatory
cytokines [9, 10]. In the present study we used monoclonal
antibodies to the a chain of LFA-l (CD! la) and to the common
(3 chain of the /32 integrins (CD!8). Within the glomerulus
PMNL expressed strong CD18 on their free surfaces and at
their sites of adhesion to intact glomerular endothelium,
whereas CD! la was only very weakly expressed on PMNL.
This suggests that on PMNL, Mac-i (CD11b/CD18), which
shares the common /3 chain with LFA-! and is recognized by
CD18, is the more important counter receptor for endothelial
ICAM-1 in the initial stages of anti-GBM GN in the rat. This
conclusion is supported by the results of recent in vivo antibody
blocking studies [2, 5]. Administration of monoclonal antibod-
ies to LFA-la (CD!la) and Mac-la (CD!lb) prior to induction
of disease in rats showed that only the latter, CDL ib, reduced
proteinuria and glomerular PMNL accumulation [2, 5]. Hence
we propose a role for up-regulated glomerular endothelial
ICAM- 1 in the accumulation of Mac-! expressing PMNL in the
gbomerulus in the initial stages of anti-GBM GN in the rat.
PMNL can cause gbomerular endothehial cell and epithelial cell
injury by the release of proteases and toxic oxygen products [6,
25].
By six hours "active appearing" macrophages were apparent
within glomeruli adherent to and migrating beneath endothe-
hum and occasionally migrating within the mesangium. These
cells expressed both surface CD! la and CDI8 representing
LFA-! expression. LFA-1 was present at the sites of leukocyte
adhesion to the gbomerular endothelium. LFA-i plays a major
role in macrophage and T cell adhesion to activated endothe-
hum by binding to ICAM- 1 [8,9,26]. The role of LFA- 1 appears
to be in strengthening adhesion to activated endothehium fol-
lowing initial tethering involving selectins [27]. LFA-! on the
surface of leukocytes requires activation prior to mediating
strong adhesion [28]. LFA-1 also appears to be important in
migration of mononuclear leukocytes through the endothelium
[29, 30]. An interesting observation in this study was the
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Fig. 4. CDJ8 in anti-GBM GN at 12 hours.
(a) CD18 is strongly expressed on the surface
of PMNL (PM) and is present at the sites of
adhesion to the glomerular endotheium
(arrows). E, glomerular endothelial cell; M,
macrophage. x 12,600. (b) This CD18
expressing PMNL (PM) is migrating and
extending a pseudopod (arrow) beneath
detached glomerular endothelium (E). Note
weak nonspecific staining of bare GBM. C,
glomerular capillary loop; YE, visceral
podocytic epithelium. x 16,000. (c) CDt la in
anti-GBM ON at 3 hours. In contrast to CD18
(Fig. 4 a, b), CDI1a is only very weakly
expressed on the surface of this PMNL
adherent to the GBM. C, glomerular capillary
lumen. X 10,000.
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Fig. 5. (a) CDI8 in anti-GBM GN at 12 hours. CDI8 is moderately expressed on the surface of this macrophage (M) and is present at the sites
of adhesion of the macrophage to the endothelium (arrows). x 22,000. (b) CD1 la in anti-GBM ON at 6 hours. CDI la is very strongly expressed
on the surface of this "active appearing" macrophage (M) migrating beneath the glomerular endothelium. CD! la is prominent at the sites of contact
of the macrophage with the endothelium (arrows) but is absent on the surface attached to the bare GBM (arrowheads). Note CD! Ia positive
staining within vacuoles in the cytoplasm of the macrophage. C, glomerular capillary loop. x 16,000. (C) CD18 in anti-GBM GN at 12 hours. At
higher magnification the glomerular endothelium (E) appears to be tethered to a macrophage (M) at a site of CD18 expression on the macrophage
surface (arrow). x 40,000.
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absence of CD1Ia and/or CD18 expression on the leukocyte
surfaces attached to GBM as compared with the prominent
expression on the surfaces in contact with glomerular endothe-
hum. This was apparent for both PMNL and macrophages and
could represent either shedding or inactivation of the /32 inte-
grin on this surface abutting bare GBM. It appears that up-
regulation of glomerular endothelial ICAM- 1 also plays a role in
the accumulation, adhesion and migration of LFA-i expressing
macrophages in the glomerulus in the later stages of anti-GBM
GN in the rat. Activated macrophages can cause progressive
renal damage by release of proteolytic enzymes, eiconasoids,
cytokines and growth factors [31].
We conclude that up-regulation of glomerular endothelial
ICAM-l in anti-GBM GN in the rat plays a role in the early
glomerular leukocytic infiltration in this disease by promoting
the adhesion of PMNL via the Mac-I ligand, and the adhesion
and migration of macrophages via the LFA-l ligand. In this way
ICAM- I could contribute to progressive glomerular injury in
this model of anti-GBM GN.
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